It is demonstrated, using immunostaining, that CART expression is naturally elevated in the brains of APP/PS1 transgenic mice and in AD patients in the Aβ plaques, perhaps as a compensatory defense mechanism. The gene discussed is CARTPT; the disease is Alzheimer disease.